Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
FDA Authorizes Pfizer, Moderna's Omicron-Based Boosters
02:48pm, Thursday, 01'st Sep 2022 Zacks Investment Research
Pfizer (PFE)/BioNTech (BNTX) and Moderna (MRNA) develop the Omicron BA.4/BA.5-adapted bivalent vaccines at the FDA's recommendation.
Pharma Stock Roundup: FDA Authorization of Omicron Boosters, SNY's Xenpozyme & More
02:41pm, Thursday, 01'st Sep 2022 Zacks Investment Research
FDA authorizes Pfizer (PFE) & Moderna's (MRNA) Omicron-aimed COVID vaccines & Sanofi's (SNY) new drug, Xenpozyme.
2 Big Red Flags and 1 Small Green Flag For Pfizer Stock
02:00pm, Thursday, 01'st Sep 2022 The Motley Fool
It has what could become a pair of big problems on its hands.
Why Novavax Stock Got Pummeled Today
10:45pm, Wednesday, 31'st Aug 2022 The Motley Fool
The coronavirus' decline is continuing; meanwhile, rival vaccine developers are still moving ahead.
Here's How Novavax Stock Could Rally Through 2023
03:23pm, Wednesday, 20'th Jul 2022 The Motley Fool
Its vaccine might be more effective as a booster than the other options.
Novavax's Shareholders Can Breathe a Sigh of Relief
02:15pm, Wednesday, 20'th Jul 2022 The Motley Fool
There is good news for the company, but there is more work to do ahead.
Novavax (NVAX) Up as CDC Endorses COVID Jab for Use in Adults
01:36pm, Wednesday, 20'th Jul 2022 Zacks Investment Research
Following the endorsement by the U.S. CDC, Novavax (NVAX) can now start immunizations with its COVID-19 vaccine as a primary two-dose regimen for use in adults in the United States.
Pfizer (PFE), BioNTech Seek EU Nod for Omicron-Based COVID Jab
01:30pm, Wednesday, 20'th Jul 2022 Zacks Investment Research
Pfizer (PFE) and BioNTech (BNTX) complete a regulatory filing for their Omicron-specific bivalent COVID-19 vaccine in the EU. The bivalent vaccine has been developed to target the Omicron BA.1 subvari
2 Struggling Stocks That Could Fall Even Further in the Second Half
10:55am, Wednesday, 20'th Jul 2022 The Motley Fool
Now may be the time to sell these stocks.
2 Things Novavax Must Do to Be a Monster Comeback Stock
09:52am, Wednesday, 20'th Jul 2022 The Motley Fool
They're not easy tasks. But Novavax could potentially achieve them.
Why Moderna Stock Bumped Higher Today
07:22pm, Tuesday, 19'th Jul 2022 The Motley Fool
The company wins yet another approval for its coronavirus vaccine.
Worried About a Recession? Check Out These 2 Passive Income Stocks
03:45pm, Tuesday, 19'th Jul 2022 The Motley Fool
Specializing in niche commercial property means it's possible to stay relevant regardless of the economy.
GSK Completes Demerger of Consumer Healthcare Business
02:24pm, Tuesday, 19'th Jul 2022 Zacks Investment Research
Post demerger, GSK is set to focus on its Pharmaceuticals and Vaccines businesses. The consumer healthcare business, Haleon, will start regular-way trading on the NYSE from Jul 22.
What Monkeypox Could Mean for These 2 Stocks?
12:45pm, Tuesday, 19'th Jul 2022 The Motley Fool
Vaccine companies saw stock prices spike during the COVID pandemic. The same could happen amid a new outbreak.
Pfizer (PFE) Dips More Than Broader Markets: What You Should Know
09:45pm, Monday, 18'th Jul 2022 Zacks Investment Research
In the latest trading session, Pfizer (PFE) closed at $50.75, marking a -1.93% move from the previous day.
